筋腫のの英語

低侵襲性で長期的投与が可能であり、かつ副作用がない又は弱い新規子宮筋腫治療薬の開発と提供を目的とする。例文帳に追加

To develop and provide a novel therapeutic agent for fibroid which is low invasive, is capable of a long-term administration, and has no or weak side effect. - 特許庁

ヒト子宮筋腫細胞及び／又はヒト子宮筋腫組織片を、細胞外マトリックス成分を含むゲル状基質と共に、機能的なT細胞及びB細胞を欠失し、かつIL-2Rγ遺伝子を破壊又は欠失した免疫不全非ヒト動物に移植する。例文帳に追加

The cells of human uterus myoma and/or a piece of human uterus myoma tissue are implanted into a nonhuman immune deficit animal with deleted functional T- and B-cells and destroyed or deleted IL-2Rγ gene, together with a gelatinous substrate including extracellular matrix components. - 特許庁

皮膚および子宮（平滑筋腫）の良性腫瘍（がんではない）と子宮（平滑筋肉腫）および腎臓の悪性腫瘍（がん）の発生リスクが増大する、まれな遺伝性疾患。例文帳に追加

a rare inherited disorder that increases the risk of developing benign (not cancer) tumors of the skin and the uterus (leiomyomas) and malignant (cancer) tumors of the uterus (leiomyosarcoma) and the kidney.発音を聞く  - PDQ®がん用語辞書 英語版

子宮組織、例えば過形成性組織などの異型性組織、筋腫および子宮新生物（腫瘍および癌を含む）の処置、発生防止および退行もしくは寛解、ならびに、良性および癌性の子宮障害の処置、ならびに過形成性および／または高張性子宮腺細胞の処置のための手段の提供。例文帳に追加

To provide means for treating, preventing the development of, and causing the regression or remission of uterine tissues, including atypical tissues, such as hyperplastic tissues, fibroids, and uterine neoplasms (including tumors and cancers), for treating uterine disorders, both benign and cancerous, as well as for treating hyperplastic and/or hypertonic uterine gland cells. - 特許庁

具体的用途としては、乳癌、思春期早発症、子宮内膜症、子宮筋腫、アルツハイマー病、循環器系疾患、更年期障害、不定愁訴、癌転移、ＰＭＳ、月経困難症、、カルシウム・リン骨代謝障害等の予防、治療薬がある。例文帳に追加

The pharmaceutical is concretely used as a prophylactic/remedial pharmaceutical for breast cancer, pubertas praecox, endometriosis, uterine myoma, Alzheimer's disease, cardiovascular diseases, menopause, maleise, metastasis of cancers, premenstrual syndrome, dysmenorrhea, metabolic disturbance of calcium and phosphorus in the bone, etc. - 特許庁